Study of Use of CTC in NSCLC

NCT01990651 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2013-11-21

No results posted yet for this study

Summary

The purpose of this study is to assess whether the detection of circulating tumor cells (CTC) could be used as a tool to earlier diagnose, more accurately predict treatment response / failure and predict overall survival in non-small cell lung cancer (NSCLC) patients

Conditions

Sponsors & Collaborators

  • University of Virginia

    lead OTHER

Principal Investigators

  • Thao Dang, MD · University of Virginia Health System

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2014-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01990651 on ClinicalTrials.gov